BNP Paribas Financial Markets
COGT icon

BNP Paribas Financial Markets’s Cogent Biosciences COGT Stock Holding History

BNP Paribas Financial Markets’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Sell
332,334
-10,748
-3% -$376K ﹤0.01% 1488
2026
Q1 		$13.2M Buy
343,082
+144,113
+72% +$5.32M 0.01% 1411
2025
Q4 		$7.07M Sell
198,969
-498,995
-71% -$14M ﹤0.01% 1821
2025
Q3 		$10M Buy
697,964
+482,550
+224% +$5.72M 0.01% 1539
2025
Q2 		$1.55M Buy
215,414
+209,227
+3,382% +$1.16M ﹤0.01% 2646
2025
Q1 		$37.1K Sell
6,187
-60,597
-91% -$475K ﹤0.01% 4378
2024
Q4 		$521K Buy
+66,784
New +$666K ﹤0.01% 3273
2022
Q4 		– Sell
-175,767
Closed -$2.62M – 4164
2022
Q3 		$2.62M Buy
+175,767
New +$2.41M ﹤0.01% 1759
2020
Q3 		– Sell
-10
Closed -$17 – 4222
2020
Q2 		$17 Sell
10
-25
-71% -$46 ﹤0.01% 4254
2020
Q1 		$58 Hold
35
– – ﹤0.01% 4236
2019
Q4 		$101 Sell
35
-530
-94% -$2.16K ﹤0.01% 4331
2019
Q3 		$3.25K Hold
565
– – ﹤0.01% 4320
2019
Q2 		$5.92K Sell
565
-508
-47% -$6.76K ﹤0.01% 4215
2019
Q1 		$18.8K Buy
1,073
+1,057
+6,606% +$18.1K ﹤0.01% 3919
2018
Q4 		$277 Sell
16
-13
-45% -$385 ﹤0.01% 4059
2018
Q3 		$1.2K Hold
29
– – ﹤0.01% 4308
2018
Q2 		$1.67K Buy
+29
New +$1.39K ﹤0.01% 4273

Other funds holding COGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

BNP Paribas Financial Markets's COGT Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Cogent Biosciences (COGT) stake by 3.1% in Q2 2026, selling an estimated $376K and leaving 332,334 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

BNP Paribas Financial Markets first reported a position in COGT in Q2 2018 and has held it in 17 quarters since. The position peaked at $13.2M in Q1 2026. 290 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • BNP Paribas Financial Markets held 332,334 shares of Cogent Biosciences worth $12.9M as of Q2 2026.
  • BNP Paribas Financial Markets sold 10,748 Cogent Biosciences shares in Q2 2026, an estimated $376K.
  • Cogent Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1488 holding.
  • BNP Paribas Financial Markets first reported a position in Cogent Biosciences in Q2 2018 and has held it in 17 quarters since.
  • BNP Paribas Financial Markets's Cogent Biosciences position peaked at $13.2M in Q1 2026.
  • 290 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.